EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -98.8% | 218,384 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $321,000 | +27.9% | 218,384 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $251,000 | -29.7% | 218,384 | +53.1% | 0.01% | 0.0% |
| Q4 2021 | $357,000 | -70.8% | 142,647 | +26.6% | 0.01% | -82.9% |
| Q4 2020 | $1,223,000 | +65.3% | 112,644 | +81.7% | 0.04% | +9.4% |
| Q3 2020 | $740,000 | +163.3% | 61,994 | +127.9% | 0.03% | +220.0% |
| Q3 2019 | $281,000 | -49.0% | 27,201 | -38.0% | 0.01% | -37.5% |
| Q2 2019 | $551,000 | +9.8% | 43,879 | +8.4% | 0.02% | -23.8% |
| Q1 2019 | $502,000 | +152.3% | 40,483 | +25.3% | 0.02% | +425.0% |
| Q4 2018 | $199,000 | +9.3% | 32,304 | +88.6% | 0.00% | -20.0% |
| Q3 2018 | $182,000 | -48.1% | 17,128 | -34.0% | 0.01% | -58.3% |
| Q2 2018 | $351,000 | -55.0% | 25,938 | -36.6% | 0.01% | -40.0% |
| Q3 2017 | $780,000 | +262.8% | 40,943 | +187.8% | 0.02% | +185.7% |
| Q2 2017 | $215,000 | – | 14,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |